Hugo Hensley
Advertisement
Articles by Hugo Hensley
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Bristol Myers Squibb Discloses Patient Death in CAR-T Multiple Sclerosis Trial
2
FDA Extends Talzenna-Xtandi to Hormone-Sensitive Prostate Cancer
3
Pathos Ai Enters Drug Development Collaboration with Bristol Myers Squibb and Tempus Ai
4
Roundup: Teva Acquires BXCL501 for $57.5 Million Upfront, Rumi Therapeutics Enters Option Agreement for Fragile X PDE2 Inhibitor From Enthorin
5